Select on of extracellular matrix components and or matricellular proteins for improved post-cryopreservation cell viability and retention
A method for cryopreservation of adherent cells attached to a substrate and a method for identifying one or more extracellular matrix (ECM) components and/or matricellular proteins that improves viability and retention of the cryopreserved cells on the substrate. The method for cryopreservation includes treating a substrate with at least one ECM component and/or adding at least one matricellular protein to the substrate or cell culture media, plating the cells on the treated substrate, and cryopreserving the cells. One or more ECM components and/or matricellular proteins that improves cell viability and retention can be identified by evaluating the cells that have been thawed from the cryopreservation temperature to determine cell viability and retention.
1. A method for cryopreservation of adherent cells on a substrate comprising:
treating a substrate with a combination of extracellular matrix components prior to plating the cells on the substrate and/or adding one or more matricellular proteins to the substrate or to the cells in a cell culture medium;
plating the cells on the substrate; and
cryopreserving the cells on the substrate by cooling the cells to a cryopreservation temperature;
wherein
the one or more matricellular proteins is selected from the group consisting of tenascin-C, tenascin-X, periostin, CCN-1, osteopontin, and mixtures thereof; and
the combination of extracellular matrix components is:
(i) fibronectin, laminin, collagen I, and collagen IV,
(ii) fibronectin, collagen III, collagen IV, and collagen V, or
(iii) collagen I, collagen III, collagen IV, and collagen V.
2. The method according to claim 1 , further comprising subsequently thawing the cells by:
first warming the cells from the cryopreservation temperature by exposing the substrate containing the cells to a first environment having a first warming temperature greater than the cryopreservation temperature; and then
further warming the cells from the first warming temperature by exposing the cells to a second environment having a second warming temperature that is greater than the first warming temperature.
3. The method according to claim 2 , wherein:
the cryopreservation temperature is at least −30° C.;
the first warming temperature is greater than −30° C. and less than 30° C.; and
the second warming temperature is at least 32° C.
4. The method according to claim 1 , wherein the cells are bovine corneal endothelial cells.
5. The method according to claim 1 , wherein the cells are human mesenchymal stem cells.
6. A method for cryopreservation of adherent cells on a substrate comprising:
adding one or more matricellular proteins to the substrate or to the cells in a cell culture medium, and optionally treating the substrate with at least one extracellular matrix component;
plating the cells on the substrate; and
cryopreserving the cells on the substrate by cooling the cells to a cryopreservation temperature;
wherein the one or more matricellular proteins is selected from the group consisting of actin-binding proteins, thrombospondin-1, tenascin-C, tenascin-X, SPARC, periostin, CCN-1, and osteopontin; and
wherein the cells are human mesenchymal stem cells.
7. The method according to claim 6 , wherein the at least one extracellular matrix component is selected from the group consisting of fibronectin, laminin, collagen I, collagen II, collagen IV, collagen V, and vitronectin.
8. The method according to claim 7 , wherein the at least one extracellular matrix component comprises at least fibronectin, collagen IV, and collagen V.
9. A method for cryopreservation of adherent cells on a substrate comprising:
adding at least one matricellular protein to a substrate or to the cells in a cell culture medium, and optionally treating the substrate with at least one extracellular matrix component;
plating the cells on the substrate; and
cryopreserving the cells on the substrate by cooling the cells to a cryopreservation temperature;
wherein the at least one matricellular protein is selected from the group consisting of actin-binding proteins, thrombospondin-1, tenascin-C, tenascin-X, periostin, CCN-1, and osteopontin.
10. The method according to claim 9 , wherein the addition of the at least one matricellular protein to the substrate or to the cells is separate from any natural production of a matricellular protein by the cells.
11. The method according to claim 9 , wherein the at least one extracellular matrix component is selected from the group consisting of fibronectin, laminin, collagen I, collagen II, collagen IV, collagen V, and vitronectin.
12. The method according to claim 9 , further comprising subsequently thawing the cells by:
first warming the cells from the cryopreservation temperature by exposing the substrate containing the cells to a first environment having a first warming temperature greater than the cryopreservation temperature; and then
further warming the cells from the first warming temperature by exposing the cells to a second environment having a second warming temperature that is greater than the first warming temperature.
13. The method according to claim 12 , wherein:
the cryopreservation temperature is at least −30° C.;
the first warming temperature is greater than −30° C. and less than 30° C.; and
the second warming temperature is at least 32° C.
14. The method according to claim 9 , wherein the cells are human mesenchymal stem cells or bovine corneal endothelial cells.
15. A method for cryopreservation of adherent cells on a substrate comprising:
treating a substrate with a combination of extracellular matrix components and/or adding at least one matricellular protein to the substrate or to the cells in a cell culture medium;
plating the cells on the substrate; and
cryopreserving the cells on the substrate by cooling the cells to a cryopreservation temperature;
wherein
the treatment of the substrate with the combination of extracellular matrix components is in addition to any natural production of an extracellular matrix component by the cells, and the combination of extracellular matrix components is:
(i) fibronectin, laminin, collagen I and collagen IV,
(ii) fibronectin, collagen III, collagen IV, and collagen V, or
(iii) collagen I, collagen III, collagen IV, and collagen V; and
the at least one matricellular protein is selected from the group consisting of tenascin-C, tenascin-X, periostin, CCN-1, osteopontin, and mixtures thereof.
16. The method according to claim 15 , further comprising subsequently thawing the cells by:
first warming the cells from the cryopreservation temperature by exposing the substrate containing the cells to a first environment having a first warming temperature greater than the cryopreservation temperature; and then
further warming the cells from the first warming temperature by exposing the cells to a second environment having a second warming temperature that is greater than the first warming temperature.
17. The method according to claim 16 , wherein:
the cryopreservation temperature is at least −30° C.;
the first warming temperature is greater than −30° C. and less than 30° C.; and
the second warming temperature is at least 32° C.
18. The method according to claim 15 , wherein the cells are human mesenchymal stem cells or bovine corneal endothelial cells.